Nanosphere Enters Into $30 Million Common Stock Purchase Agreement With Aspire Capital
18. März 2014 17:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 18, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has entered into a Common...
Nanosphere to Present at the 26th Annual ROTH Conference
06. März 2014 12:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 6, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the...
Nanosphere to Host Investor Day on March 20th in New York
03. März 2014 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 3, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will host an Investor...
Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13
05. Februar 2013 10:07 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its results...
Nanosphere Receives FDA Clearance for C. difficile Test
10. Dezember 2012 15:26 ET
|
Nanosphere, Inc.
Comprehensive sample-to-result test detects potentially deadly C. difficile and identifies 027 hypervirulent strain
Expands menu of infectious disease tests on Verigene®...
Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
29. November 2012 09:47 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
Nanosphere to Present at Piper Jaffray 24th Annual Healthcare Conference
21. November 2012 10:51 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 21, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism
13. November 2012 07:45 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today the US...
Nanosphere Announces Third Quarter 2012 Results
07. November 2012 16:01 ET
|
Nanosphere, Inc.
50 new VerigeneSP system placements double over prior quarter
C. difficile assay filed with FDA
FDA categorizes blood stream gram-positive test as CLIA moderate complexity
NORTHBROOK,...
Nanosphere to Present at Lazard Capital Markets and Stephens Inc. Investor Conferences
06. November 2012 09:29 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...